BRCA1 Promoter Methylation in Cancer Research
Exciting new research continues to highlight the significance of BRCA1 promoter methylation in cancer research. A growing body of research has linked BRCA1 methylation with triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSOC), with recent studies using the MethylDetect EpiMelt BRCA1 Assay to detect even low-variant-epiallele-fraction (VEF) BRCA1 epimutations. The connection between BRCA1 methylation, TNBC, and homologous recombination deficiency (HRD) further emphasizes the importance of sensitive, reliable methylation analysis.
MethylDetect EpiMelt Assays provide fast, highly sensitive detection of locus-specific methylation using MS-HRM while minimizing PCR bias. With assay-specific methylated and non-methylated controls, EpiMelt Assays support accurate, reproducible methylation analysis across cancer, cell cycle, inflammatory response, tumor suppressor genes, and more. Assays and controls are available for more than 800 genes, providing a versatile solution for DNA methylation research.
View the publications below:
- Schwartz, M., Ibadioune, S., Delhomelle, H., et al. (2025). High prevalence of constitutional BRCA1 epimutation in patients with early-onset triple-negative breast cancer. Clinical Epigenetics, 17, 91.
- Pasanisi, J., Lamy, C., Lecompte, L., et al. (2026). Constitutional BRCA1 methylation is associated with high level of tumoral BRCA1 methylation and homologous recombination deficiency in triple-negative breast cancer. npj Breast Cancer.
- Lønning, P. E., Nikolaienko, O., Pan, K., et al. (2022). Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer. JAMA Oncology, 8(11), 1579–1587. Note: This study discusses the importance of studying BRCA1 promoter methylation in breast cancer research but did not use the MethylDetect Kit.
We also offer our EpiMelt’s Bisulfite Modification Standard Kit and Real-Time PCR Mastermix to complete your workflow!
Learn more about our MethylDetect DNA Methylation Kits. Request a quote.

Our new CRISPR & Gene Expression range from Cellecta delivers innovative tools and workflows for gene editing, helping you achieve efficient and reliable results across a wide range of applications. These solutions include pooled lentiviral CRISPR libraries, gene activation and repression systems, screening tools, and supporting reagents that enable researchers to perform both large-scale and targeted studies of gene function.
We are thrilled to announce the addition of ADS Biotec to our portfolio! ADS Biotec provides a range of products designed to enhance productivity in Cytogenetics, Molecular Genetics, and Pathology. 
We are pleased to announce that Boca Scientific Inc. will be attending Immunology 2026 and would like to invite you to stop by our booth #639!
We are excited to announce the launch of e-Myco™ VALiD-Q Real-time PCR Kit (v3.0 PRO). This kit provides a fast, reliable, and guideline-compliant method to detect mycoplasma contamination in cell-based manufacturing processes. The assay offers comprehensive coverage of international pharmacopeia standards (EP, USP, JP, and Korea MFDS), enabling simultaneous detection of compendial reference species within a single integrated panel.
Agrisera provides off-the-shelf
We are thrilled to share a landmark, multi-company validation showing home-cage monitoring detects CNS safety signals missed by traditional Irwin/FOB testing. Home Cage Analyzer offers welfare benefits, and increased sensitivity for 24/7 data capture!
Join us in San Diego, CA November 16-19th for Neuroscience 2025!
Enjoy the last month of summer with our exciting new promotion! For each unit purchased of our
We are excited to announce we will be attending analytica USA 2025 in Columbus, Ohio! Join us September 10th-12th to learn more about Boca Scientific and our wide range of cutting edge research solutions.